Novamind reports revenues of CAD$1.86 million for Q1 fiscal 2022, a 113% year-over-year increase. The company has total working capital of CAD$6.8 million
Pure Extracts Corp
Company Brief
Pure Extracts uses CO2 extraction technology to derive full spectrum oil from cannabis biomass. We are an emerging leader in the extraction space offering only the purest quality oil.
Highlights
Related Articles
Novamind Unveils New Logo and Invests in Unified Brand
Novamind announces unified branding of all subsidiaries and brands, and includes a new corporate logo.
TSI EDITOR |
2021-11-24
Seelos Therapeutics Raises $20 Million in Private Placement of Senior Secured Convertible Note
Seelos Therapeutics announces $20 million in new funding via convertible note, with an option for an additional $30 million.
TSI EDITOR |
2021-11-24
COMPASS Pathways granted fifth US patent for crystalline psilocybin
The 5th USPTO patent for Compass Pathways covers methods of treating depression with crystalline psilocybin.
TSI EDITOR |
2021-11-23
Industry Buzz Growing Rapidly Around MINDCURE’s iSTRYM
Digital therapeutics is the key to the rapid commercialization of psychedelic medicine. MINDCURE's iSTRYM digital therapeutics platform is the first-mover in the industry.
TSI EDITOR |
2021-11-22
Psychedelics-Assisted Therapy: Effective, Economical AND Imperative
Psychedelic medicine is both extremely efficacious and highly cost-effective. It is also an absolute necessity to RESCUE the economy.
TSI EDITOR |
2021-11-18
Latest Stories
NEW BULL MARKET ALERT
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now